DS1 spectrogram: Diagnosis, Bad Planning & Reasoning. Treatment, SCOPE -- Planning for Hybrid Querying over Clinical Trial Data

Diagnosis, Bad Planning & Reasoning. Treatment, SCOPE -- Planning for Hybrid Querying over Clinical Trial Data

April 28, 20262604.25120

Authors

Tejas Anvekar,Muhammad Ali Khan,Kaneez Zahra Rubab Khakwani,Mohamad Bassam Sonbol,Irbaz Bin Riaz

Abstract

We study clinical trial table reasoning, where answers are not directly stored in visible cells but must be reasoned from semantic understanding through normalization, classification, extraction, or lightweight domain reasoning. Motivated by the observation that current LLM approaches often suffer from "bad reasoning" under implicit planning assumptions, we focus on settings in which the model must recover implicit attributes such as therapy type, added agents, endpoint roles, or follow-up status from partially observed clinical-trial tables.

We propose SCOPE (Structured Clinical hybrid Planning for Evidence retrieval in clinical trials), a multi-LLM planner-based framework that decomposes the task into row selection, structured planning, and execution. The planner makes the source field, reasoning rules, and output constraints explicit before answer generation, reducing ambiguity relative to direct prompting.

We evaluate SCOPE on 1,500 hybrid reasoning questions over oncology clinical-trial tables against zero-shot, few-shot, chain-of-thought, TableGPT2, Blend-SQL, and EHRAgent. Results show that explicit multi-LLM planning improves accuracy for reasoning-based questions while offering a stronger accuracy-efficiency tradeoff than heavier agentic baselines.

Our findings position clinical trial reasoning as a distinct table understanding problem and highlight hybrid planner-based decomposition as an effective solution

Resources

Stay in the loop

Every AI paper that matters, free in your inbox daily.

Details

  • © 2026 takara.ai Ltd
  • Content is sourced from third-party publications.